Individual and Additive Effects of the CNR1 and FAAH Genes on Brain Response to Marijuana Cues

被引:95
作者
Filbey, Francesca M. [1 ,2 ]
Schacht, Joseph P. [1 ,3 ,4 ]
Myers, Ursula S. [1 ]
Chavez, Robert S. [1 ]
Hutchison, Kent E. [1 ,2 ]
机构
[1] Mind Res Network, Albuquerque, NM 87106 USA
[2] Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA
[3] Univ Colorado, Dept Psychol, Boulder, CO 80309 USA
[4] Univ Colorado, Dept Neurosci, Boulder, CO 80309 USA
基金
美国国家卫生研究院;
关键词
CNR1; FAAH; genes; marijuana; cannabis; fMRI; ACID-AMIDE-HYDROLASE; CANNABIS DEPENDENCE SYMPTOMS; ENDOCANNABINOID SYSTEM; MOTION CORRECTION; CB1; RECEPTORS; OPTIMIZED EPI; DRD4; VNTR; ASSOCIATION; ALCOHOL; DRUG;
D O I
10.1038/npp.2009.200
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
As previous work has highlighted the significance of the cannabinoid receptor 1 (CNR1) and fatty acid amide hydrolase (FAAH) genes with respect to cannabis dependence (CD), this study sought to characterize the neural mechanisms that underlie these genetic effects. To this end, we collected DNA samples and fMRI data using a cue-elicited craving paradigm in thirty-seven 3-day-abstinent regular marijuana users. The participants were grouped according to their genotype on two single-nucleotide polymorphisms (SNPs) earlier associated with CD phenotypes: rs2023239 in CNR1 and rs324420 in FAAH. Between-group comparisons showed that carriers of the CNR1 rs2023239 G allele had significantly greater activity in reward-related areas of the brain, such as the orbitofrontal cortex (OFC), inferior frontal gyrus (IFG), and anterior cingulate gyrus (ACG), during exposure to marijuana cues, as compared with those with the A/A genotype for this SNP. The FAAH group contrasts showed that FAAH rs324420 C homozygotes also had greater activation in widespread areas within the reward circuit, specifically in the OFC, ACG, and nucleus accumbens (NAc), as compared with the FAAH A-allele carriers. Moreover, there was a positive correlation between neural response in OFC and NAc and the total number of risk alleles (cluster-corrected p < 0.05). These findings are in accord with earlier reported associations between CNR1 and FAAH and CD intermediate phenotypes, and suggest that the underlying mechanism of these genetic effects may be enhanced neural response in reward areas of the brain in carriers of the CNR1 G allele and FAAH C/C genotype in response to marijuana cues. Neuropsychopharmacology (2010) 35, 967-975; doi:10.1038/npp.2009.200; published online 9 December 2009
引用
收藏
页码:967 / 975
页数:9
相关论文
共 57 条
[1]   Evidence for Association Between Polymorphisms in the Cannabinoid Receptor 1 (CNR1) Gene and Cannabis Dependence [J].
Agrawal, Arpana ;
Wetherill, Leah ;
Dick, Danielle M. ;
Xuei, Xiaoling ;
Hinrichs, Anthony ;
Hesselbrock, Victor ;
Kramer, John ;
Nurnberger, John I., Jr. ;
Schuckit, Marc ;
Bierut, Laura J. ;
Edenberg, Howard J. ;
Foroud, Tatiana .
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 2009, 150B (05) :736-740
[2]   Candidate genes for cannabis use disorders: findings, challenges and directions [J].
Agrawal, Arpana ;
Lynskey, Michael T. .
ADDICTION, 2009, 104 (04) :518-532
[3]   Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors [J].
Arnone, M ;
Maruani, J ;
Chaperon, F ;
Thiebot, MH ;
Poncelet, M ;
Soubrie, P ;
LeFur, G .
PSYCHOPHARMACOLOGY, 1997, 132 (01) :104-106
[4]   (AAT)n repeat in the cannabinoid receptor gene (CNR1):: association with cocaine addiction in an African-Caribbean population [J].
Ballon, N ;
Leroy, S ;
Roy, C ;
Bourdel, MC ;
Charles-Nicolas, A ;
Krebs, MO ;
Poirier, MF .
PHARMACOGENOMICS JOURNAL, 2006, 6 (02) :126-130
[5]   General multilevel linear modeling for group analysis in FMRI [J].
Beckmann, CF ;
Jenkinson, M ;
Smith, SM .
NEUROIMAGE, 2003, 20 (02) :1052-1063
[6]   Cannabinoid receptor and WIN 55 212-2-stimulated [35S]-GTPγS binding in the brain of mu-, delta- and kappa-opioid receptor knockout mice [J].
Berrendero, F ;
Mendizábal, V ;
Murtra, P ;
Kieffer, BL ;
Maldonado, R .
EUROPEAN JOURNAL OF NEUROSCIENCE, 2003, 18 (08) :2197-2202
[7]   Lack of CB1 cannabinoid receptors modifies nicotine behavioural responses, but not nicotine abstinence [J].
Castañé, A ;
Valjent, E ;
Ledent, C ;
Parmentier, M ;
Maldonado, R ;
Valverde, O .
NEUROPHARMACOLOGY, 2002, 43 (05) :857-867
[8]   Lack of response suppression follows repeated ventral tegmental cannabinoid administration:: An in vitro electrophysiological study [J].
Cheer, JF ;
Marsden, CA ;
Kendall, DA ;
Mason, R .
NEUROSCIENCE, 2000, 99 (04) :661-667
[9]   Reduced cellular expression and activity of the P129T mutant of human fatty acid amide hydrolase: evidence for a link between defects in the endocannabinoid system and problem drug use [J].
Chiang, KP ;
Gerber, AL ;
Sipe, JC ;
Cravatt, BF .
HUMAN MOLECULAR GENETICS, 2004, 13 (18) :2113-2119
[10]   The endocannabinoid system as a target for the treatment of cannabis dependence [J].
Clapper, Jason R. ;
Mangieri, Regina A. ;
Piomelli, Daniele .
NEUROPHARMACOLOGY, 2009, 56 :235-243